UBS AM’s Sagimet Biosciences SGMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.89K Buy
+495
New +$4.55K ﹤0.01% 3911

Other funds holding SGMT

UBS AM's SGMT Position: Q3 2026 in Review

UBS AM opened a new position in Sagimet Biosciences (SGMT) in Q3 2026: 495 shares worth $4.89K. The stake represents ﹤0.01% of the portfolio and ranks #3911 among its holdings.

128 funds tracked by Wall St. Rank hold SGMT as of Q3 2026.

  • UBS AM held 495 shares of Sagimet Biosciences worth $4.89K as of Q3 2026.
  • Sagimet Biosciences was a new UBS AM position in Q3 2026.
  • Sagimet Biosciences made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #3911 holding.
  • 128 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q3 2026.

Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.